Innovations in Regenerative Treatments

EmCyte Corporation® is the world leader in autologous Platelet Rich Plasma and Progenitor Stem Cell Biologics. Its product portfolio meets the highest achievable performance standard at the point of care.

It has an innovation that remains on the cutting edge of excellence and improves clinical outcomes for patients around the world. More power, versatility, efficiency, and quality at the point of care.

Miami-based plastic and reconstructive surgeon Dr. George M. Varkarakis explains that the human body contains powerful healing properties that are unlike anything in the world. The body has an array of proteins and cell mediators that can identify and repair damaged tissue in the body. These tissue types are found in the blood, bone marrow, and adipose cells. EmCyte’s President/CEO Patrick Pennie talks about their patented technology, which effectively concentrates these tissue types into a powerful treatment sample that can be applied to an injury or wound.